Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China.

Escuriola Ettingshausen, Carmen; Yang, Renchi; Wu, Wenman; Meeks, Shannon L

Escuriola Ettingshausen, Carmen; Yang, Renchi; Wu, Wenman; Meeks, Shannon L.

Afiliación

Escuriola Ettingshausen C; HZRM Hemophilia Center Rhine-Main, Frankfurt-Mörfelden, Mörfelden-Walldorf, Germany.
Yang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Wu W; Department of Laboratory Medicine, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Meeks SL; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA.

Haemophilia ; 28 Suppl 4: 111-118, 2022 May.

Article en En | MEDLINE | ID: mdl-35521731

Asunto(s)

Hemofilia A; Factor IX/uso terapéutico; Factor VIII/uso terapéutico; Hemofilia A/diagnóstico; Hemofilia A/tratamiento farmacológico; Hemorragia/diagnóstico; Hemorragia/tratamiento farmacológico; Hemorragia/prevención & control; Humanos; Tolerancia Inmunológica; Proteínas Recombinantes/uso terapéutico

Palabras clave

bypassing agents; haemophilia; immune tolerance; inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google